Holen Sie sich die Stockscreener-App
45.76
0.62%
0.25
Schlusskurs vom Vortag:
$45.51
Offen:
$45.7
24-Stunden-Volumen:
3,052
Relative Volume:
0.06
Marktkapitalisierung:
$229.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.08%
1M Leistung:
-1.84%
6M Leistung:
+11.30%
1J Leistung:
+25.21%
1-Tages-Spanne:
$45.54
$45.70
1-Wochen-Bereich:
$44.39
$46.30
52-Wochen-Spanne:
$36.49
$48.76
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Firmenname
Spdr Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| XPH | 45.54 | 229.97M | 0 | 0 | 0 | 0.00 |
| VTI | 294.03 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 591.59 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 594.55 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 253.13 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 502.38 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Aktie (XPH) Neueste Nachrichten
Objective long/short (XPH) Report - Stock Traders Daily
Here's Why a Handful of Pharmaceutical Stocks Rose Wednesday - MSN
Pharma stocks fall as Trump picks vaccine skeptic Robert F. Kennedy Jr. for US health job - USA TODAY
What Are Wall Street Analysts' Target Price for Zoetis Stock? - Inkl
Global Pharma carries the most overweight allocations in Nov – according to BofA’s Global FMS - MSN
(XPH) Long Term Investment Analysis - Stock Traders Daily
Barrick Gold Corp (GOLD-N) QuotePress Release - The Globe and Mail
Boeing Company (BA-N) QuotePress Release - The Globe and Mail
Johnson & Johnson (JNJ-N) QuotePress Release - The Globe and Mail
Are Wall Street Analysts Predicting Viatris Stock Will Climb or Sink? - Inkl
5 Biggest Pharmaceutical ETFs in 2024 - Investing News Network
7 Best-Performing Biotech ETFs for November 2024 - NerdWallet
Select Sector SPDR ETFs Offer Targeted Investment Opportunities Across Economic Sectors - Citybuzz
(XPH) Investment Analysis and Advice - Stock Traders Daily
Best Biotech ETFs to Watch Right Now - The Motley Fool
XLV: 3 Healthcare ETFs to Buy for Defensive Growth - StockNews.com
Healthcare bankruptcies slow after peaking in 2023: report - MSN
Here's exactly how to prepare for a Trump or Harris presidency — and how to build a 5-part 'election-proof portfolio' - Business Insider
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike - MSN
What's the State of the Market? We'll Let the Charts Do the Talking - TheStreet
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)? - MSN
The Technology Select Sector SPDR Fund (XLK) Stock Price, News, Quote & History - Yahoo Finance
How to Take Advantage of moves in (XPH) - Stock Traders Daily
6 Best Health Care ETFs to Buy Now | Investing - U.S News & World Report Money
Commonwealth Equity Services LLC Acquires 602 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Hancock Whitney Corp Acquires 1,440 Shares of SPDR S&P Emerging Markets SmallCap ETF (NYSEARCA:EWX) - Defense World
The Energy Select Sector SPDR Fund (XLE) Stock Price, News, Quote & History - Yahoo Finance
Trend Tracker for (XPH) - Stock Traders Daily
Ashton Thomas Private Wealth LLC Makes New Investment in SPDR MSCI ACWI ex-US ETF (NYSEARCA:CWI) - Defense World
Healthcare Stocks Have Popped. Consider These 2 That Haven’t. - Barron's
XLV: 3 Healthcare ETFs to Buy for Broad Sector Exposure - StockNews.com
A State Street Fund Excels in Rough Year for Healthcare Stocks - Kiplinger's Personal Finance
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
SPDR Bloomberg High Yield Bond ETF (NYSEARCA:JNK) Shares Sold by Wealth Enhancement Advisory Services LLC - Defense World
Comerica Bank Sells 2,311 Shares of SPDR Bloomberg 3-12 Month T-Bill ETF (NYSEARCA:BILS) - Defense World
Envestnet Portfolio Solutions Inc. Acquires 1,510 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
IBB: 3 Biotech ETFs for a Diversified Portfolio - StockNews.com
Pharma ETFs in Focus Post Solid Q2 Earnings - Yahoo Finance
Disruptive Theme of the Week: Playing Defense - ETFdb.com
SPDR Portfolio S&P 1500 Composite Stock Market ETF (NYSEARCA:SPTM) Stock Price Up 1.6% - Defense World
TSX 60 Shariah Index (TXSI) QuotePress Release - The Globe and Mail
268 Shares in SPDR S&P Dividend ETF (NYSEARCA:SDY) Bought by Opal Wealth Advisors LLC - Defense World
Price T Rowe Associates Inc. MD Purchases 920 Shares of SPDR S&P MidCap 400 ETF Trust (NYSEARCA:MDY) - Defense World
2 Biotech Stocks to Buy Hand Over Fist in August - AOL
Cetera Advisors LLC Has $953,000 Stock Position in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
SPDR Portfolio S&P 600 Small Cap ETF (NYSEARCA:SPSM) Shares Purchased by GAMMA Investing LLC - Defense World
SPDR S&P 400 Mid CapGrowth ETF (NYSEARCA:MDYG) Shares Sold by Park Avenue Securities LLC - Defense World
Is SPDR Russell 1000 Yield Focus ETF (ONEY) a Strong ETF Right Now? - Yahoo Finance
First 2x ETF Tied to Blazing Hot Eli Lilly Debuts - etf.com
Vanguard Group Inc. Raises Stock Holdings in SPDR S&P Dividend ETF (NYSEARCA:SDY) - American Banking and Market News
Best health care ETFs: Top biotech, pharma and medical funds - Bankrate.com
Finanzdaten der Spdr Pharmaceuticals Etf-Aktie (XPH)
Es liegen keine Finanzdaten für Spdr Pharmaceuticals Etf (XPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.99%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):